LIU WJ, Tan S, Zhao M, Quan C, et al. Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions. J Infect Dis. 2016 Oct 12
BACKGROUND:
?The emergence of infections by the novel avian influenza A (H7N9) virus has posed a threat to human health. Cross-immunity between H7N9 and other heterosubtypic influenza viruses affected by antigenicity-dependent substitutions needs to be investigated.
METHODS:
?We investigated the cellular and humoral immune responses against H7N9 and the 2009 pandemic H1N1 influenza viruses, by serological and T-cell-specific assays in a healthy population. The molecular bases of the cellular and humoral antigenic variability of H7N9 were illuminated by structural determination.
RESULTS:
?We not only found antibodies against H7N9 were lacking in the studied population, but also revealed both CD4+ and CD8+ T-cells that cross-reacted with H7N9 were at significantly lower levels than those against the 2009pH1N1 peptides with substitutions. Moreover, individual peptides for the H7N9 virus with low cross-reactivity were identified. Structural determination indicated that substitutions within these peptides influence the antigenic variability of H7N9 through both major histocompatibility complex (MHC)-binding and T-cell receptor (TCR)-docking.
CONCLUSIONS:
?The impact of antigenicity-dependent substitutions on cross-reactivity of T-cell immunity against the novel H7N9 virus in the healthy population benefits the understanding of immune evasion of influenza viruses and provides a useful reference for universal vaccine development.
?The emergence of infections by the novel avian influenza A (H7N9) virus has posed a threat to human health. Cross-immunity between H7N9 and other heterosubtypic influenza viruses affected by antigenicity-dependent substitutions needs to be investigated.
METHODS:
?We investigated the cellular and humoral immune responses against H7N9 and the 2009 pandemic H1N1 influenza viruses, by serological and T-cell-specific assays in a healthy population. The molecular bases of the cellular and humoral antigenic variability of H7N9 were illuminated by structural determination.
RESULTS:
?We not only found antibodies against H7N9 were lacking in the studied population, but also revealed both CD4+ and CD8+ T-cells that cross-reacted with H7N9 were at significantly lower levels than those against the 2009pH1N1 peptides with substitutions. Moreover, individual peptides for the H7N9 virus with low cross-reactivity were identified. Structural determination indicated that substitutions within these peptides influence the antigenic variability of H7N9 through both major histocompatibility complex (MHC)-binding and T-cell receptor (TCR)-docking.
CONCLUSIONS:
?The impact of antigenicity-dependent substitutions on cross-reactivity of T-cell immunity against the novel H7N9 virus in the healthy population benefits the understanding of immune evasion of influenza viruses and provides a useful reference for universal vaccine development.
See Also:
Latest articles in those days:
- High-throughput pseudovirus neutralisation maps the antigenic landscape of influenza A/H1N1 viruses 16 hours ago
- Timely vaccine strain selection and genomic surveillance improve evolutionary forecast accuracy of seasonal influenza A/H3N2 16 hours ago
- Evaluation of a Novel Data Source for National Influenza Surveillance: Influenza Hospitalization Data in the National Healthcare Safety Network, United States, September 2021-April 2024 16 hours ago
- Scenarios for pre-pandemic zoonotic influenza preparedness and response 16 hours ago
- Stability of Avian Influenza A(H5N1) Virus in Milk from Infected Cows and Virus-Spiked Milk 2 days ago
[Go Top] [Close Window]
